BriaCell Therapeutics Corp. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BCTX Nasdaq 2834 briacell.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BriaCell Therapeutics Corp.

BriaCell Therapeutics Announces Closing of US$30 million Public Offering - Jan 15th, 2026 2:05 pm
Top Midday Decliners - Jan 14th, 2026 12:10 pm
Big Bank Earnings, Inflation Data in Focus as US Equity Futures Slip Pre-Bell - Jan 14th, 2026 6:58 am
BriaCell Therapeutics Announces Pricing of $30 million Public Offering - Jan 13th, 2026 7:00 pm
Top Midday Gainers - Jan 13th, 2026 11:54 am
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient - Jan 13th, 2026 5:30 am
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine - Dec 18th, 2025 5:30 am
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 - Dec 10th, 2025 5:30 am
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - Dec 9th, 2025 5:30 am
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 - Dec 2nd, 2025 5:30 am
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025 - Nov 25th, 2025 5:30 am
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics - Nov 20th, 2025 5:30 am
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025 - Nov 18th, 2025 5:30 am
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 - Nov 7th, 2025 5:30 am
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models - Nov 4th, 2025 5:30 am
Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding - Oct 28th, 2025 2:01 am
Top 3 Earnings Acceleration Buys for November - Oct 27th, 2025 1:05 pm
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - Oct 22nd, 2025 5:30 am
BriaCell Adds Three Cancer Centres to Phase 3 Study, Works With MSK Accelerator to Advance Bria-OTS+ - Oct 21st, 2025 6:16 am
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study - Oct 21st, 2025 5:50 am